Staidson Beijing Biopharma (300204)

Currency in CNY
49.90
+0.47(+0.95%)
Closed·
300204 Scorecard
Full Analysis
Impressive gross profit margins
300204 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
47.9250.94
52 wk Range
5.9057.19
Key Statistics
Bid/Ask
49.90 / 49.90
Prev. Close
49.43
Open
49
Day's Range
47.92-50.94
52 wk Range
5.9-57.19
Volume
14.16M
Average Volume (3m)
35.85M
1-Year Change
585.56%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300204 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.24
Upside
+10.70%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Staidson Beijing Biopharma Company Profile

Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium Chloride Capsules, Gliclazide extended-release tablets, Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.

Employees
492
Market
China

Compare 300204 to Peers and Sector

Metrics to compare
300204
Peers
Sector
Relationship
P/E Ratio
−164.7x−20.0x−0.5x
PEG Ratio
−2.680.300.00
Price/Book
24.8x7.4x2.6x
Price / LTM Sales
80.6x20.1x3.3x
Upside (Analyst Target)
10.7%0.6%43.4%
Fair Value Upside
Unlock−13.2%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 55.24
(+10.70% Upside)

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
63.21M / --
EPS Revisions
Last 90 days

300204 Income Statement

FAQ

What Stock Exchange Does Staidson Beijing Biopharma Trade On?

Staidson Beijing Biopharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Staidson Beijing Biopharma?

The stock symbol for Staidson Beijing Biopharma is "300204."

What Is the Staidson Beijing Biopharma Market Cap?

As of today, Staidson Beijing Biopharma market cap is 23.84B.

What Is Staidson Beijing Biopharma's Earnings Per Share (TTM)?

The Staidson Beijing Biopharma EPS (TTM) is -0.30.

From a Technical Analysis Perspective, Is 300204 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Staidson Beijing Biopharma Stock Split?

Staidson Beijing Biopharma has split 4 times.

How Many Employees Does Staidson Beijing Biopharma Have?

Staidson Beijing Biopharma has 492 employees.

What is the current trading status of Staidson Beijing Biopharma (300204)?

As of 08 Aug 2025, Staidson Beijing Biopharma (300204) is trading at a price of 49.90, with a previous close of 49.43. The stock has fluctuated within a day range of 47.92 to 50.94, while its 52-week range spans from 5.90 to 57.19.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.